PMC:7264098 / 25059-25313 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T354","span":{"begin":81,"end":85},"obj":"UBERON:0002048"},{"id":"T355","span":{"begin":150,"end":155},"obj":"UBERON:0000170"},{"id":"T94609","span":{"begin":81,"end":85},"obj":"UBERON:0002048"},{"id":"T87082","span":{"begin":150,"end":155},"obj":"UBERON:0000170"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}

{"project":"LitCovid-PubTator","denotations":[{"id":"460","span":{"begin":81,"end":93},"obj":"Disease"}],"attributes":[{"id":"A460","pred":"tao:has_database_id","subj":"460","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T189","span":{"begin":81,"end":85},"obj":"Body_part"},{"id":"T190","span":{"begin":150,"end":155},"obj":"Body_part"}],"attributes":[{"id":"A189","pred":"fma_id","subj":"T189","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A190","pred":"fma_id","subj":"T190","obj":"http://purl.org/sig/ont/fma/fma68877"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T45","span":{"begin":81,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A45","pred":"uberon_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T149","span":{"begin":81,"end":93},"obj":"Disease"}],"attributes":[{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T265","span":{"begin":16,"end":17},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T266","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T267","span":{"begin":81,"end":85},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T268","span":{"begin":150,"end":155},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T269","span":{"begin":159,"end":160},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}

{"project":"LitCovid-sentences","denotations":[{"id":"T146","span":{"begin":0,"end":254},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":73,"end":93},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0006528"}],"text":"As evident from a number of clinically available inhaled medications for chronic lung disease, the inhalation route of delivering therapeutics to the lungs is a more direct route with lower incidence of adverse effects, compared to the intravenous route."}